Health Aging. Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician

Similar documents
Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

Hypertension Management Controversies in the Elderly Patient

2017Adult Male Preventive Health Guidelines

Preventive Health Guidelines

Diabetes and Hypertension

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

The Latest Generation of Clinical

DEPARTMENT OF GENERAL MEDICINE WELCOMES

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Diabetes and the Heart

American Diabetes Association 2018 Guidelines Important Notable Points

To Do or Not To Do? The Annual Physical- Beyond The PAP And Breast Exam

2018 Adult Female Preventive Health Guidelines

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Jared Moore, MD, FACP

2019 Adult Preventive Health Guidelines

PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION

Update in Outpatient Medicine JNC 8, Hypertension and More

ADVANCES IN MANAGEMENT OF HYPERTENSION

Hypertension JNC 8 (2014)

major public health burden

ADVANCES IN MANAGEMENT OF HYPERTENSION

Diabetes Mellitus in Older Adults. Presenter Disclosure Information

Wayne Gravois, MD August 6, 2017

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Managing Hypertension in 2016

Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy

Dr Tahseen A. Chowdhury Royal London Hospital. New Guidelines in Diabetes: NICE or Nasty?

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Nutritional Recommendations for the Diabetes Managements

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Jennifer Loh, MD, FACE Chief of Endocrinology KP Hawaii AAMD of Medical Education, KP Hawaii

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

Treating the elderly patients with type 2 diabetes mellitus

Hypertension in the very old. Objectives: Clinical Perspective

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

A Practical Approach to the Use of Diabetes Medications

Adult Female Preventive Health Guidelines

Standards of Medical Care in Diabetes 2016

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

Egyptian Hypertension Guidelines

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

Established Risk Factors for Coronary Heart Disease (CHD)

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus

STATE OF THE STATE: TYPE II DIABETES

Update in Hypertension

The ABCs (A1C, BP and Cholesterol) of Diabetes

Key causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:

Non-insulin treatment in Type 1 DM Sang Yong Kim

CLINICAL PRACTICE GUIDELINE

The Many Faces of T2DM in Long-term Care Facilities

Standards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Objectives. Kidney Complications With Diabetes. Case 10/21/2015

The Failing Heart in Primary Care

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Diabetes Mellitus: Evaluation and Care Management

Preventing and Treating High Blood Pressure

American Diabetes Association: Standards of Medical Care in Diabetes 2015

The Diabetes Link to Heart Disease

Section 1: 1: Trends. Section 2: 2: Comparisons to to Overall Portland Area Area Results for for

Practical and Detail Oriented Quality Improvement Intervention Model for Cardiovascular Disease

Objectives. Describe results and implications of recent landmark hypertension trials

Preventive Care Guideline for Asymptomatic Elderly Patients Age 65 and Over

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

OLD AND NEW DRUGS FOR CONTROLING DIABETES THERAPEUTIC CLASSES AND MECHANISM OF ACTION

Combination Therapy for Hypertension

What s In the New Hypertension Guidelines?

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

CASE A2 Managing Between-meal Hypoglycemia

A Guidance Statement from the American College of Physicians

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

Hypertension Pharmacotherapy: A Practical Approach

Diabetes Mellitus: Implications of New Clinical Trials and New Medications

Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone

Eugene Barrett M.D., Ph.D. University of Virginia 6/18/2007. Diagnosis and what is it Glucose Tolerance Categories FPG

Older Adults & Optimal Outcome. Individualizing Diabetes Management. Mary Moyer Janci BC-FNP BC-ADM CDE Teaching Associate Diabetes Care Center UWMC

7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)

MPharmProgramme. Hypertension (HTN)

Wisconsin Chronic Disease Quality Improvement Project. HEDIS 2017 Summary Data

Blood Pressure LIMBO How Low To Go?

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Kaiser Permanente Complete Care. Michael H. Kanter, MD Medical Director of Quality and Clinical Analysis

Hypertension Update. Objectives 4/28/2015. Beverly J. Mathis, D.O. OOA May 2015

Modern Management of Hypertension: Where Do We Draw the Line?

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Rationalizing Medications. Tan Jianming Senior Pharmacist KTPH

Treating Hypertension in 2018: What Makes the Most Sense Today?

Drugs to Treat Type 2 DM Demonstrate Reductions in Major Adverse Cardiovascular Events

Office Management of Reduced GFR Practical advice for the management of CKD

New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD

Preventive Services Explained

8/5/2017. Disclosure to Participants. Learning Outcomes. Terry Compton MS, APRN, CDE. Seniors with Diabetes: Why Are They Different?

Type 2 Diabetes: Where Do We Start with Treatment? DIABETES EDUCATION. Diabetes Mellitus: Complications and Co-Morbid Conditions

Geriatric Pearls 2016

Diabetic Management in the Frail Older Patient

Transcription:

Health Aging Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician

What is Healthy Aging?

Charles Eugster 96 years young!

Stanislaw Kowalski 104 at European Masters Athletics Championships

Baltimore Longitudinal Study of Aging People who sociable, generous, goal orientated higher levels of happiness and lower rates of depression People involved in hobbies and leisure activities lower risk for some health problems Diet rich in vegetables, fruit, low in saturated fat decreased CVD and mortality Benefits of Exercise

OC population by Age Group

Diabetes management in the Elderly Over 65 with DM high priority depression screening and treatment Avoid hypoglycemia Functional and cognitive intact, with long expectancy similar goals to younger pts May relaxed glycemic goals in certain individuals

ADA guidelines 2016 for elderly Avoid symptomatic hyperglycemia or acute hyperglycemia complications Individualize screening diabetic complications, close attention to those leading functional complications CV risk factors: HTN treatment, ASA/lipid therapy to patient with benefit

Pharmacologic treatment Cost with polypharmacy may be big factor Drug class Meformin 1 st line, CI CKD, significant CHF Sulfonylureas, secreatagogues Insulin* GLP-1 receptor antagonists*, DPP-4 inhibitors SGLT2 inhibitors Hypoglycemia, use with caution, glyburide CI in elderly Hypoglycemia Few side effects, costly Limited long term experience * Need cognitive ability, good eyesight, motor skills or caregiver

Hypertension in the elderly Elderly: lower baseline CO, Higher TPR, wider PP, lower intravascular volume and lower RBF SBP < 150 (JNC 8) SBP < 140 DM, CKD (JNC 8) SBP < 140 fit elderly with IHD

Non pharmacology management Exercise Modest weight reduction in obese Dietary sodium Treatment of sleep apnea

Hypertension Therapy Consider: fragility, ability follow instructions, complexity of current meds, supporting care Current meds: NSAIDs, decongestants Labs: Electrolytes, renal function (ACEi/ARB) Often need multiple agents at higher doses JNC8: ACEi, CCB, Diuretics, not BB ACEi: (DM, CKD with proteinuria CHF, IHD) Thiazides: HypoK, hypona

What screening would you do for a 65 year male and female in your clinic?

USPTF Grading System Grade Definition Suggestion for practice A High benefit/certainty Offer/provide B Moderate benefit/certainty Offer/provide C Individualize, moderate certainty small benefit Offer/provide on select patients D Moderate certainty no net benefit or harms > benefit Discourage I Insufficient evidence Patients to understand uncertainty

Colorectal screening 50-75 years (A), 76 85 years (C) >85 years (D) CT colonoscopy and fecal DNA testing (I)

Lung cancer screening 55-80 years, 30pack year, smoke or quit within 15 years (B) Annual Low-dose CT scan

Breast Cancer screening Biennial screening with mammogram 50 74 years (B) Breast cancer screening with dense breasts adjunct imaging (I)

Cardiovascular related screening Healthy diet and physical activity adults increased CVD risk (B) RF: HTN, HLD, Impaired fasting glucose, BMI>25 High blood pressure screening every 2 years DM type 2 screening 40-70 years who are overweight or obese (B) Hb1aC, OTT, Q3years Tobacco smoking cessation behavioral and pharmacological intervention (A)

Cardiovascular related screening Obesity (BMI>30) offer intensive, multicomponent behavioral interventions (B) Statin use age 40-70 No Cardiac history, 1 more CV risk factor, CVD risk >10% (B) AAA screening Males 65-75 years smoked (>100cig) (B)

Mental Health screening Alcohol misuse (B) AUDIT-C Depression screening (B) Geriatric depression Scales

Chronic infectious diseases screening Hep B screening adults high risk: MSM, IVDU, ESRF on HD, not vaccinated, immigrant (B) Hep C screening adults born 1946-1965, Hx of IVDU (B) HIV screening 15 to 65 years, older increased risk (A) LTBI screening increase risk

Falls prevention Over 65 -> exercise (B) HHS 150min per week moderate intensity, or 75min/week high intensity + 2 days strength + 3 days/week balance (w/ falls risk) AGS 800IU/day increased falls risk (B) CDC vision, medications, home assessment Osteoporosis: Screening women > 65 years (B)

Summary: Healthy Aging Useful to know regional population health statistics where you practice Population/community vs individual approach Importance of social history 1o prevention = diet, exercise, healthy lifestyle.. 2o prevention = screening (USPTF) 3o prevention = prevent/reduce complications.. DM Hb1aC goals, avoid hypos, metformin, insulin HTN CCB, may need multiple, goal SBP ~150 Go low, go slow with medications Multi-disciplinary team approach

Questions?

Health Aging Xaviour Walker MD, MPH, DTMH UCI Geriatric Fellow Hospitalist, Public Health and Preventive Medicine Physician